RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases with comprehensive and sustainable solutions.
RareStone Group consists of two business subsidiaries: Citrine Medicine and Zircon Health.
Citrine Medicine is a pharmaceutical company aiming to provide effective and affordable treatment solutions to rare disease patients in China. Citrine Medicine is building a comprehensive rare disease product platform through fast licensing and co-development to support and accelerate scalable commercialization.
Zircon Health is a Health technology company aiming to build the largest patient-centered open ecological service platform in China with the help of cutting-edge technology. Zircon Health will leverage Internet digital tools, big data, and artificial intelligence technologies to improve the awareness of rare diseases, promote disease screening and diagnosis, carry out full-cycle disease management, and explore various payment innovations, providing comprehensive and one-stop health service solutions for patients and families affected by rare diseases.